Source: International Congress 2019 – Effects of pulmonary rehabilitation other than improving exercise capacity
Disease area: -



Rating:

Share or cite this content

Citations should be made in the following way:
R. Beijers (Maastricht, Netherlands). Modulation of cardiometabolic risk by pulmonary rehabilitation. International Congress 2019 – Effects of pulmonary rehabilitation other than improving exercise capacity

Member's Comments

No comment yet.

Related content which might interest you: Correlates and assessment of excess cardiovascular risk in bronchiectasis Source: Eur Respir J, 50 (5) 1701127; 10.1183/13993003.01127-2017 Year: 2017 Incidence and specific risk factors of falling in pulmonary rehabilitation Source: Annual Congress 2010 - Pulmonary rehabilitation: understanding and developing the intervention Year: 2010 Risk assessment, therapy and cardiovascular comorbidity in patients with pulmonary arterial hypertension Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020 Prevalence of comorbidities and impact on pulmonary rehabilitation outcomes Source: ERJ Open Res, 5 (4) 00264-2019; 10.1183/23120541.00264-2019 Year: 2019 Cardiometabolic risk profile in muscle wasted COPD patients with abdominal obesity and the effect of pulmonary rehabilitation Source: International Congress 2016 – New insights into pulmonary rehabilitation for chronic lung diseases Year: 2016 Metabolic risk factors in patients with advanced COPD and the response to short-term high-intensity pulmonary rehabilitation Source: International Congress 2015 – Best abstracts on pulmonary rehabilitation in chronic lung diseases Year: 2015 Impact of obesity on pulmonary rehabilitation in COPD patients Source: Annual Congress 2011 - Challenges in rehabilitation: some old dilemmas revisited with some solutions? Year: 2011 Novel biomarkers for risk stratification in pulmonary arterial hypertension Source: ERJ Open Res 2015; 1: 00008-2015 Year: 2015 MPAP/CO-slope during exercise as predictor of mortality in patients at risk for pulmonary hypertension. Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension Year: 2020 Spirometry for the risk stratification of cardiovascular disease among the elderly Source: Eur Respir J 2007; 30: Suppl. 51, 311s Year: 2007 Frequency of occurrence of risk factors of cardiovascular diseases and assessment of the total cardiovascular risk in patients with chronic obstructive pulmonary disease (COPD). Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Determinants and assessment of excess cardiovascular risk in bronchiectasis Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives Year: 2015 Prevalence of cardiovascular risk factors and coronary artery disease in patients with COPD Source: Annual Congress 2010 - COPD: cardiovascular comorbidities Year: 2010 Analysis of mortality risk factors in a population with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension Source: Annual Congress 2010 - Pulmonary hypertension Year: 2010 Comparison of risk assessment strategies for not-high-risk pulmonary embolism Source: Eur Respir J 2016; 47: 1170-1178 Year: 2016 Risk stratification and prognostic factors in patients with pulmonary arterial hypertension and comorbidities Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020 Modifiable risk factors for all-cause hospitalization in obstructive lung disease Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD Year: 2015 Analysis of risk factors in pulmonary thromboembolism Source: Eur Respir J 2006; 28: Suppl. 50, 45s Year: 2006 The frequency of chronic thromboembolic pulmonary hypertension and associated risk factors Source: Annual Congress 2011 - Prediction of pulmonary thromboembolism Year: 2011